We are live on ! Find out more
IHE icon

iShares US Pharmaceuticals ETF
IHE

98 hedge funds and large institutions have $148M invested in iShares US Pharmaceuticals ETF in 2018 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 22 increasing their positions, 30 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more call options, than puts

Call options by funds: $3.56M | Put options by funds: $1.96M

45% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 11

11% more capital invested

Capital invested by funds: $133M → $148M (+$14.3M)

3% more funds holding

Funds holding: 95 → 98 (+3)

13.83% less ownership

Funds ownership: 111.28% → 97.45% (-14%)

27% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 30

Holders
98
Holders Change
+3
Holders Change %
+3.16%
% of All Funds
2.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
22
Reduced
30
Closed
11
Calls
$3.56M
Puts
$1.96M
Net Calls
+$1.59M
Net Calls Change
-$1.75M

Top Buyers

Rank Fund Capital Flow
1
CIBC World Market
CIBC World Market
Ontario, Canada
+$4.01M
2
Citadel Advisors
Citadel Advisors
Florida
+$2.88M
3
RWP
RWA Wealth Partners
Massachusetts
+$2.01M
4
Jane Street
Jane Street
New York
+$1.36M
5
Bank of America
Bank of America
North Carolina
+$1.07M

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$5.59M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$3.22M
3
Ameriprise
Ameriprise
Minnesota
-$2.24M
4
FPGK
Financial Partners Group (Kansas)
Kansas
-$2.14M
5
CWM
Cornerstone Wealth Management
Missouri
-$1.89M
Name Holding Trade Value Shares
Change 		Change in
Stake
FCMT
76
Founders Capital Management (Texas)
Texas
$48K – – –
SWMG
77
Signature Wealth Management Group
Georgia
$47K – – –
RFC
78
Regions Financial Corp
Alabama
$30K – – –
FFW
79
Fusion Family Wealth
New York
$29K – – –
Fifth Third Bancorp
80
Fifth Third Bancorp
Ohio
$29K +$4.92K +90 +21%
GWM
81
Geneos Wealth Management
Colorado
$25K – – –
SC
82
Sawyer & Company
Massachusetts
$24K – – –
GRP
83
Global Retirement Partners
California
$22K +$164 +3 +0.8%
KL
84
KWMG LLC
Kansas
$20K – – –
DSC
85
Duncker Streett & Co
Missouri
$17K – – –
EDRH
86
Edmond de Rothschild Holding
Switzerland
$17K – – –
ICM
87
IMS Capital Management
Oregon
$17K +$16.4K +300 New
RWA
88
River Wealth Advisors
Pennsylvania
$13K – – –
CAG
89
Csenge Advisory Group
Florida
$13K +$14.8K +270 New
AIM
90
Anchor Investment Management
South Carolina
$10.1K – – –
AA
91
AlphaMark Advisors
Kentucky
$8K – – –
Northwestern Mutual Wealth Management
92
Northwestern Mutual Wealth Management
Wisconsin
$8K – – –
S
93
SignatureFD
Georgia
$8K – – –
TPWA
94
TRUE Private Wealth Advisors
Oregon
$6.73K +$6.56K +120 New
BCWM
95
Bartlett & Co Wealth Management
Ohio
$5.05K – – –
BC
96
Bartlett & Co
Ohio
$5K – – –
TFA
97
Transamerica Financial Advisors
Florida
$1K – – –
FPGK
98
Financial Partners Group (Kansas)
Kansas
– -$2.14M -42,426 Closed
Goldman Sachs
99
Goldman Sachs
New York
– -$698K -13,839 Closed
SG Americas Securities
100
SG Americas Securities
New York
– -$450K -8,925 Closed
1 2 3
4
5

IHE Hedge Fund Activity: Q3 2018 in Review

98 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in iShares US Pharmaceuticals ETF (IHE) for Q3 2018, worth a combined $148M — up 11% from $133M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new IHE positions and 11 closed out — a net gain of 5 holders — while 22 added to existing stakes and 30 trimmed.

The largest buyer was CIBC World Market, opening a new position worth an estimated $4.01M. The largest seller was Susquehanna International Group, cutting an estimated $5.59M.

  • 98 institutional investors held iShares US Pharmaceuticals ETF (IHE) as of Q3 2018, up from 95 in Q2 2018.
  • Funds reported $148M of iShares US Pharmaceuticals ETF stock for Q3 2018, up 11% quarter-over-quarter.
  • 16 funds opened new iShares US Pharmaceuticals ETF positions in Q3 2018 and 11 closed out, a net change of +5 holders.
  • The largest iShares US Pharmaceuticals ETF buyer in Q3 2018 was CIBC World Market, an estimated $4.01M added.
  • The largest iShares US Pharmaceuticals ETF seller in Q3 2018 was Susquehanna International Group, an estimated $5.59M sold.

Based on aggregated 13F filings for Q3 2018.